Overview: To increase the awareness of the new long-term care (LTC) osteoporosis guidelines, improve appropriate osteoporosis prescribing, and document LTC residents who are at high risk for fracture, and those who fall & fracture. GOAL is a knowledge translation initiative targeted at inter-professional teams in 50 LTC homes across the province. This collaborative quality improvement program was delivered by McMaster University and Medical Pharmacy Group Limited.


ClinicalTrials.gov Identifier: NCT01887392
Study Type: Interventional (Clinical Trial)
Participants (N): 6800
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Intervention Description: Two interactive sessions will be delivered to the interprofessional team at Month 1 and Month 6 and are 1 hour in length. The Clinical Consultant Pharmacist at each LTC home will lead the Knowledge Translation Sessions. Participants will watch an educational video, developed by the co-investigators with expertise in osteoporosis and geriatrics and members of the Ontario College of Family Physicians. Accompanying materials that support the topics in the video will be provided. Following the educational video, one of the experts from the video will phone the LTC home to address questions and provide the home with direct access to an expert.
Primary Outcome Difference in the percentage of residents appropriately prescribed an osteoporosis medication before and after the intervention.
Results GOAL results were presented at the International Osteoporosis Foundation meeting in Milan, Italy and suggested that a prior diagnosis of osteoporosis, prior clinical vertebral fractures, and current glucocorticoid use are factors that trigger the use of osteoporosis medications in high risk residents.